Evocalcet has been used in trials studying the treatment of Hyperparathyroidism and Secondary Hyperparathyroidism. It is grouped under the following drug class(es): Calcimimetics. Its source/manufacturing origin is listed as synthetic. Other names for this substance include 4-((3S)-3-(((1R)-1-(1-Naphthalenyl)ethyl)amino)-1-pyrrolidinyl)benzeneacetic acid and orkedia. Its PubChem CID is 71242808.
Evocalcet
| CAS No | 870964-67-3 |
|---|---|
| Molecular Formula | C24H26N2O2 |
| Molecular Weight | 374.5 g/mol |
| Synonyms | 2-[4-[(3S)-3-[[(1R)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Evocalcet has been used in trials studying the treatment of Hyperparathyroidism and Secondary Hyperparathyroidism. It is grouped under the following drug class(es): Calcimimetics.
The listed CAS number is 870964-67-3.
The listed molecular formula is C24H26N2O2.
The listed molecular weight is 374.5 g/mol.
2-[4-[(3S)-3-[[(1R)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic acid.
The source lists 4-((3S)-3-(((1R)-1-(1-Naphthalenyl)ethyl)amino)-1-pyrrolidinyl)benzeneacetic acid and orkedia.